{
  "id": "SCR-LIP-000629",
  "statement": "Lipedema may be associated with a more favorable plasma lipid profile than obesity, though adiposity-matched comparisons are inconsistent.",
  "claim_type": "clinical_association",
  "context": {
    "population": "women with lipedema (mean BMI 28.9)",
    "condition": "lipedema",
    "exposure": "lipedema diagnosis (vs healthy controls)",
    "comparator": "healthy female controls",
    "outcome": "plasma lipid profile and metabolic indices",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.3389/fimmu.2023.1223264",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2023,
      "amato_authored": false,
      "note": "The article reports a favorable lipid profile and preserved metabolic parameters in lipedema patients, indirectly relevant to the metabolic protection aspect of the question, but it does not directly test whether gynoid/peripheral fat distr",
      "title": "Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis",
      "authors": "Kruppa et al.",
      "journal": "Frontiers in Immunology",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "stance adopted from independent verifier (context→supporting). The article confirms all specific numbers cited (HDL 1.65 vs 1.04 mmol/L, LDL:HDL ratio, triglyceride:HDL ratio, preserved HOMA-IR, fasting glucose, insulin, mean BMI 28.9, stag",
        "date": "2026-06-10"
      },
      "quote": "HDL colesterol lipedema 1,65±0,46 vs controles 1,04±0,27 mmol/l (p<0,0001); razão LDL:HDL 1,65±0,65 vs 2,96±0,62 (p<0,0001); razão triglicérides:HDL 0,72±0,36 vs 1,21±0,33 (p=0,0001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Lipedema vs controls: HDL 1.65 vs 1.04 mmol/L (p<0.0001), lower LDL:HDL (1.65 vs 2.96) and triglyceride:HDL ratios; no difference in fasting glucose, insulin or HOMA-IR.",
      "from_claims": [
        "SCR-LIP-000151"
      ]
    },
    {
      "ref": "DOI:10.3390/biomedicines13040867",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2025,
      "amato_authored": false,
      "note": "The article directly tests whether gynoid/peripheral fat distribution is associated with better metabolic markers, finding via multivariate PCA that greater limb (vs abdominal) fat independently predicts more favorable lipid, glycemic and u",
      "title": "Metabolic Alterations in Women with Lipedema Compared to Women with Lifestyle-Induced Overweight/Obesity",
      "authors": "Jeziorek et al.",
      "journal": "Biomedicines",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article directly reports all the specific numbers cited in the statement (n=53 vs 55, TG/LDL/HDL/HbA1c/HOMA-IR/uric acid comparisons, insulin resistance prevalence 11.3% vs 34.5% p=0.01), and the PCA finding that fat distribution (PC3, ",
        "date": "2026-06-10"
      },
      "quote": "Maior proporção de gordura nas extremidades protege o perfil metabólico independentemente do peso total. Apesar do IMC elevado, mulheres com lipedema apresentam menos alterações metabólicas do que mulheres com sobrepeso/obesidade de origem comportamental.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "53 lipedema vs 55 lifestyle-induced overweight/obesity (higher BMI): lower TG, LDL-C, HbA1c, HOMA-IR, uric acid, higher HDL-C, insulin resistance 11.3% vs 34.5%; limb-vs-abdominal fat best predicted favorable markers.",
      "from_claims": [
        "SCR-LIP-000300"
      ]
    },
    {
      "ref": "DOI:10.1111/obr.13953",
      "stance": "contradicting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2025,
      "amato_authored": false,
      "note": "The review reports that femoral/gynoid fat accumulation in lipedema is associated with higher whole-body insulin sensitivity and reduced inflammation versus BMI-matched obesity, supporting a metabolically protective peripheral fat phenotype",
      "title": "Lipedema: Progress, Challenges, and the Road Ahead",
      "authors": "Cifarelli",
      "journal": "Obesity Reviews",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "Human review: this review reports NO significant HbA1c difference, conflicting with the lower-HbA1c specific (from a sibling primary); stance supporting→refines (qualifies the metabolic-protection claim).",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "whole-body insulin sensitivity ~48% maior (p<0,05) em Obese-LIP vs. Obese por clamp hiperinsulinêmico-euglicêmico; sem diferenças significativas em glicemia de jejum, insulina, HbA1c, lipídios plasmáticos, OGTT ou sensibilidade hepática à insulina entre grupos",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "Review of the matched clamp study reports ~48% higher insulin sensitivity in obese lipedema but no significant differences in plasma lipids, fasting glucose, insulin, HbA1c or OGTT versus obese controls.",
      "from_claims": [
        "SCR-LIP-000152"
      ]
    },
    {
      "ref": "DOI:10.1590/1677-5449.202600752",
      "stance": "context",
      "study_design": "cross_sectional",
      "n": 4986,
      "risk_of_bias": "moderate",
      "year": 2026,
      "title": "Peripheral fat distribution, the lipedema-associated phenotype, and lower prevalence of cardiometabolic disease in women: a cross-sectional study (NHANES 2011-2018)",
      "authors": "Amato ACM, Amato JLS, Benitti DA",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "quote": "High cholesterol 1,118 0.66 (0.52-0.84) 0.002",
      "finding": "In 4,986 NHANES women, the DXA peripheral fat phenotype (not diagnosed lipedema) was associated with lower odds of a binary high-cholesterol outcome (16.9% vs 30.1%; OR 0.66, 95%CI 0.52-0.84; adjusted for body-fat category, age, race/ethnicity, smoking). No lipid values were analyzed and the comparison was women below the cutoff, not obese women; cross-sectional.",
      "extraction_confidence": "high",
      "verification": {
        "method": "single-model (Claude Code subagent)",
        "verifier_model": "claude-sonnet (subagent, fresh context)",
        "primary_model": "claude-opus-5-5 (session)",
        "quote_grounded": true,
        "date": "2026-11-20",
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "Verifier disputed 'supporting' (binary outcome, no lipid values, not vs obesity); adopted its stance (context) and wording — arbitration, not re-verified.",
        "arbitration": true
      },
      "added": "2026-11-20",
      "quote_location": "Table 3",
      "note": "Population phenotype, not diagnosed lipedema vs obesity.",
      "translation_ref": "DOI:10.1590/1677-5449.202600751",
      "amato_authored": true
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000151",
    "SCR-LIP-000300",
    "SCR-LIP-000152"
  ],
  "questions_consolidated": [
    "SQ-LIP-000010"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00241",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000010"
    },
    {
      "date": "2026-11-20",
      "event": "evidence added",
      "detail": "finding from DOI:10.1590/1677-5449.202600752 (context)"
    }
  ],
  "statement_pt": "O lipedema pode estar associado a um perfil lipídico plasmático mais favorável do que a obesidade, embora as comparações pareadas por adiposidade sejam inconsistentes.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000010",
      "role": "supporting",
      "question": "Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000010.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000629.html"
}